| mRNA |
Bosutinib |
FIMM |
pan-cancer |
AAC |
0.029 |
0.9 |
| mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |